Adcentrx Therapeutics' ADRX-0405 granted Chinese regulatory IND clearance to treat late-stage solid tumours

Curasight reports encouraging preliminary Phase 1 data for uTREAT in glioblastoma

OriCell's GPC3 CAR-T Phase II hepatocellular carcinoma trial receives Chinese regulatory clearance

Owkin to build AI agents as part of K Pro collaboration with Sanofi

Arcus Biosciences enters clinical trial collaboration with Bristol Myers Squibb in kidney cancer programme

Lupin and Natco secure US FDA approval for generic Eribulin Mesylate Injection

Evogene completes Phase 1 study of BMC128 in combination with Nivolumab

Cumberland Pharmaceuticals and Vanderbilt Health report data from Phase 2a trial of ifetroban to prevent cancer metastasis

Creatv Bio partners with Neovia Oncology to study multiple drug resistance in solid tumours

FDA accepts Genentech's giredestrant application for early-stage breast cancer

Amgen receives EU marketing authorisation for IMDYLLTRA in ES-SCLC

Anixa secures Canadian patent milestone for ovarian cancer vaccine

Rallybio and Avenzo Therapeutics announce merger agreement and USD215m financing

IBA launches Cyclone iKure for industrial-scale Astatine-211 production

Circio and GenAssist announce gene therapy research collaboration for muscle diseases and in vivo cell therapy